AGH is making more revenue than CAN and AC8, yet their MCs are lower. Your ratio is also incredibly inaccurate as you're not properly mapping out the full year revenue based on their reported patient growth.
If you really are going to solely base valuations of cannabis companies on a revenue multiple you're delusional - these aren't teclo companies.
Rebound time, page-327
-
- There are more pages in this discussion • 268 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.15M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 508 | 2.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 33310 | 1 |
View Market Depth
| Last trade - 16.12pm 12/07/2024 (20 minute delay) ? |
| AGH (ASX) Chart |
Day chart unavailable